Chemoimmunotherapy outcomes and prognostic factors in patients with advanced, low PD-L1-expressing non-small cell lung cancer.

Hata T, Yamada T, Goto Y, Amano A, Negi Y, Watanabe S, Furuya N, Oba T, Ikoma T, Nakao A, Tanimura K, Taniguchi H, Yoshimura A, Fukui T, Murata D, Kaira K, Shiotsu S, Hibino M, Okada A, Chihara Y, Kawachi H, Kijima T, Takayama K

Autoimmune-associated hemophagocytic syndrome complicated by anti-MDA5 antibody-positive dermatomyositis successfully treated with immunosuppressive therapy: A case report.

Kamada R, Hibino M, Higa H, Watanabe S, Maeda K, Ishikawa N, Kakutani T, Kondo T

Impact of Sex and Age on Trends of Mortality From Infective Endocarditis in High-Income Countries.

Hibino M, Ueyama HA, Verma R, Teoh H, Yanagawa B, Bhatt DL, Verma S

Utility of serum CYFRA 21-1 as a prognostic biomarker in ALK-positive non-small cell lung cancer treated with ALK-TKIs: a retrospective cohort study.

Sawada R, Yamada T, Goto Y, Negi Y, Nakao A, Yoshimura A, Furuya N, Oba T, Hibino M, Nakatani H, Taniguchi H, Ohtsubo A, Watanabe S, Yamada T, Chihara Y, Kijima T, Takayama K

Outcomes of chemotherapy with or without immunotherapy in older patients with non-small cell lung cancer and low PD-L1 expression.

Kawachi H, Hata T, Yamada T, Goto Y, Amano A, Negi Y, Watanabe S, Furuya N, Oba T, Ikoma T, Nakao A, Tanimura K, Taniguchi H, Yoshimura A, Fukui T, Murata D, Kaira K, Shiotsu S, Hibino M, Okada A, Chihara Y, Kijima T, Takayama K

Impact of EGFR Mutation Subtypes on Response to Chemoimmunotherapy and Chemotherapy in Non-Small-Cell Lung Cancer After EGFR-TKI Failure.

Morimoto K, Yamada T, Furuya N, Tanaka H, Yoshimura A, Oba T, Hibino M, Fukuda T, Goto Y, Nakao A, Ogusu S, Okazaki Y, Harada T, Ota T, Masubuchi K, Mikami K, Hata T, Matsumoto S, Honda R, Date K, Chihara Y, Kawachi H, Takayama K

Regimen Selection for Chemoimmunotherapy in Nonsquamous Non-Small Cell Lung Cancer with Low PD-L1 Expression: A Multicenter Retrospective Cohort Study.

Hata T, Yamada T, Goto Y, Amano A, Negi Y, Watanabe S, Furuya N, Oba T, Ikoma T, Nakao A, Tanimura K, Taniguchi H, Yoshimura A, Fukui T, Murata D, Kaira K, Shiotsu S, Hibino M, Okada A, Chihara Y, Kawachi H, Kijima T, Takayama K

An effective approach to modulate mitochondrial function in murine primary macrophages by a mitochondria-targeted nanocapsule, MITO-Porter.

Hibino M, Filosi T, Carrion LL, Porcu E, Malhotra A, LĂźdtke-Buzug K, Ibrahim SM, Yamada Y, Hirose M

Impact of immune-related adverse events on clinical outcomes in patients with advanced non-small cell lung cancer with low PD-L1 expression, focusing on pneumonitis: a multicenter retrospective study in Japan.

Goda S, Yamada T, Morimoto K, Hata T, Goto Y, Amano A, Negi Y, Watanabe S, Furuya N, Oba T, Ikoma T, Nakao A, Tanimura K, Taniguchi H, Yoshimura A, Fukui T, Murata D, Kaira K, Shiotsu S, Okada A, Hibino M, Chihara Y, Kijima T, Takayama K

Association of increased red blood cell distribution width with adverse cardiorenal outcomes after cardiac surgery.

Verma R, Hibino M, Dhingra NK, Patel SK, Mehta C, Shehata N, Yau TM, Mazer CD

Tobacco smoking and the risk of aortic dissection in the UK Biobank and a meta-analysis of prospective studies.

Khan MYI, Dillman A, Sanchez-Perez M, Hibino M, Aune D

Impact of TTF-1 Expression on the Prognostic Prediction of Patients with Non-Small Cell Lung Cancer with PD-L1 Expression Levels of 1% to 49%, Treated with Chemotherapy vs. Chemoimmunotherapy: A Multicenter, Retrospective Study.

Nishioka N, Hata T, Yamada T, Goto Y, Amano A, Negi Y, Watanabe S, Furuya N, Oba T, Ikoma T, Nakao A, Tanimura K, Taniguchi H, Yoshimura A, Fukui T, Murata D, Kaira K, Shiotsu S, Hibino M, Okada A, Chihara Y, Kawachi H, Kijima T, Takayama K

Public assistance and survival equality in patients with EGFR mutation-positive lung cancer.

Uryu K, Imamura Y, Shimoyama R, Mase T, Fujimura Y, Hayashi M, Ohtaki M, Otani K, Hibino M, Horiuchi S, Fukui T, Fukai R, Chihara Y, Iwase A, Yamada N, Tamura Y, Harada H, Tsuya A, Okabe T, Fukuoka M, Minami H

Comparing Cardiovascular Outcomes Among Heated Tobacco Product Users, Cigarette Smokers, Former Smokers, and Never Smokers: Protocol for a Real-World Retrospective Study in Japan.

Karcher H, Hibino M, Higashiue S, Haidar M, Chowdhury B, Picavet P, Boakye D, Lenart A

Chronic Obstructive Pulmonary Disease Outcomes Among Individuals in Japan Who Switched to Heated Tobacco Products Compared to Those Who Continued Smoking or Formerly Smoked Combustible Cigarettes: Protocol for a Real-World Retrospective Study.

Karcher H, Hibino M, Higashiue S, Boakye D, Chowdhury B, Picavet P, Haidar M, Lenart A